|
KIAA1715 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.72469999895719E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.26389999472099E-08 |
| Normal-vs-Stage2 |
6.137800E-03 |
| Normal-vs-Stage3 |
1.33790000000911E-06 |
| Normal-vs-Stage4 |
4.97870000004674E-06 |
| Stage1-vs-Stage2 |
1.561590E-01 |
| Stage1-vs-Stage3 |
8.355800E-01 |
| Stage1-vs-Stage4 |
6.153200E-01 |
| Stage2-vs-Stage3 |
1.857580E-01 |
| Stage2-vs-Stage4 |
1.594170E-01 |
| Stage3-vs-Stage4 |
7.684000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.66480001900982E-09 |
| Normal-vs-AfricanAmerican |
2.821900E-02 |
| Normal-vs-Asian |
2.47449999999372E-05 |
| Caucasian-vs-AfricanAmerican |
1.013990E-01 |
| Caucasian-vs-Asian |
9.410200E-01 |
| AfricanAmerican-vs-Asian |
1.668190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88359999819809E-08 |
| Normal-vs-Female |
2.90869999974852E-07 |
| Male-vs-Female |
1.781630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.64770000047277E-07 |
| Normal-vs-Age(41-60Yrs) |
1.45840000076447E-08 |
| Normal-vs-Age(61-80Yrs) |
1.182490E-04 |
| Normal-vs-Age(81-100Yrs) |
3.370500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.989600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.298800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.566800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.243760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.432200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.097400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.515400E-01 |
| Classical-VS-Follicular |
4.145600E-01 |
| Classical-VS-Other |
1.026000E-01 |
| Classical-VS-Normal |
8.16899999867005E-08 |
| Tall-VS-Follicular |
1.728840E-01 |
| Tall-VS-Other |
2.510800E-01 |
| Tall-VS-Normal |
5.65860000000251E-05 |
| Follicular-VS-Other |
1.240010E-01 |
| Follicular-VS-Normal |
1.156770E-03 |
| Other-VS-Normal |
8.579800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.29639999968801E-07 |
| Normal-vs-N1 |
2.90810000524999E-08 |
| N0-vs-N1 |
6.022400E-02 |
|
|
